Neuropsychiatric Risks of COVID: New Data

The neuropsychiatric ramifications of severe COVID-19 infection appear to be no different than for other severe acute respiratory infections (SARI). Results of a large study showed risks of new neuropsychiatric illness were significantly and similarly in adults surviving either severe COVID-19 infection or other SARI, compared with the general population. This suggests that disease severity, … Read more

TBI Linked to ‘Striking’ Risk for CVD, Endocrine, Brain Disorders

Mild traumatic brain injury (TBI) is linked to a significantly increased risk for a host of subsequent cardiovascular, endocrine, neurologic, and psychiatric disorders, new research shows. Incident of hypertension, coronary heart disease, diabetes, stroke, depression, and dementia all began to increase soon after the brain injury and persisted over a decade in both mild and … Read more

Impaired Vision an Overlooked Dementia Risk Factor

Impaired vision in older adults is an underrecognized and modifiable dementia risk factor, new research suggests. Investigators analyzed estimated population attributable fractions (PAFs) associated with dementia in more than 16,000 older adults. A PAF represents the number of dementia cases that could be prevented if a given risk factor were eliminated. Results showed the PAF … Read more

Virtual Reality an ‘Exciting Opportunity’ for Geriatric Psychiatry

Researchers are reality turning their attention to virtual VR for the treatment of psychiatric disorders in older adults. Recent studies have highlighted the usefulness of VR in treating depression and loneliness in older patients who may be socially isolated because of their age, comorbidities, or the COVID-19 pandemic. Dr Harmehr Sekhon “The unique capability of … Read more

Long-Term Cannabis Use Linked to Dementia Risk Factors

Long-term cannabis use is linked to hippocampal atrophy and poorer cognitive function in midlife — known risk factors for dementia. A large prospective, longitudinal study showed long-term cannabis users had an intelligence quotient (IQ) decline from age 18 to midlife (mean 5.5 IQ points), poorer learning and processing speed compared to childhood, and self-reported memory … Read more

New Data Focus Need for Tailored Schizophrenia Care in Elderly

Older adults with schizophrenia are not a homogenous patient population, with various subgroups that differ significantly in terms of comorbid illness and mortality rates and causes, new research shows. For example, individuals in a group characterized by substance use disorders (SUDs) had a depression prevalence of about 60% and relatively high death rates from unintentional … Read more

Restoring ‘Sixth Sense’ May Reduce Falls in Alzheimer’s

Loss of vestibular function is a key contributor to a well-documented increased risk for falls in patients with Alzheimer’s disease (AD), new research confirms. Falls are twice as common in patients with AD vs older individuals without the disorder and significantly increase the likelihood of institutionalization. However, researchers recorded fewer falls in patients with a … Read more

A Boon for Neither the Heart nor the Mind

Loneliness is associated with cerebral and cardiovascular diseases, according to recent studies. A study published last month in the journal Neurology, for example, suggests that loneliness is linked to an increased risk for dementia. Increased Risk for Dementia For this study, the authors retrospectively analyzed data that were collected prospectively from the population-based cohorts in … Read more

New Guidance on Palliative Care for Neurologic Disorders

The American Academy of Neurology (AAN) has released new expert guidance on palliative care for patients with stroke, dementia, Parkinson’s disease, and other neurologic disorders. Palliative care includes much more than hospice services, lead author of the new position statement Lynne P. Taylor, MD, University of Washington, Seattle, and a fellow of the AAN, said … Read more

Biological Evidence for Anxiety in Long COVID

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Investigators have found biochemical evidence of brain injury in patients hospitalized with acute COVID-19 and in those with long COVID. Combined blood biomarker evidence of neuronal damage activation of glial cells, indicating brain inflammation, correlated with symptoms of anxiety in long … Read more